(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Dysautonomia Orthostatic Hypotension Syndrome
Jonathann Kuo, MDSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Dysautonomia Orthostatic Hypotension Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LEVODOPA Julien Bally | Phase 1/2 | CCC |
carbidopa Julien Bally | Phase 1/2 | CCC |
Ampreloxetine Theravance Biopharma | Phase 2 | CC |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →